ProMIS Neurosciences PMN
NASDAQ PMN
$9.40 +0.02 (+0.21%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProMIS Neurosciences (PMN) Cash from Investing Activities (2021 - 2022)

Updated

ProMIS Neurosciences (PMN) reported Cash from Investing Activities of -$702.00 for FY2025, compared with -$693.00 in FY2024.

Analysis

ProMIS Neurosciences (PMN) Cash from Investing Activities (2021 - 2022) Analysis & Trends

Dating back to FY2021, ProMIS Neurosciences' Cash from Investing Activities record includes 5 years.

  • Five-year annual Cash from Investing Activities spans a low of -$1,981 in FY2022 and a high of $94,618 in FY2021.
  • According to Business Quant data, Cash from Investing Activities came in at -$693.00 in FY2024, -$1,349 in FY2023, -$1,981 in FY2022 and $94,618 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 ProMIS Neurosciences 84.30 Mn -54.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 43.00
Sep 30, 2022 24.00
Jun 30, 2022 9.00
Mar 31, 2022 -2,057.00
Dec 31, 2021 95,805.00
Sep 30, 2021 -3,559.00
API Access

ProMIS Neurosciences Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=PMN&period=max&api_key=YOUR_API_KEY